Abstract
In Britain, the specialty of palliative medicine continues to develop, encouraging the referral of patients early in the palliative phase of their illness. This had led to an increased number of patients receiving palliative chemotherapy and hospice care concurrently, posing special problems to the professionals involved. In this retrospective study, 52 patients were identified who received chemotherapy and hospice care simultaneously. Case notes were reviewed to reveal problems arising from sharing the duty of care. The poor quality of communication between professionals, perhaps reflecting a limited understanding of the various roles in patient care, we found to cause significant difficulties. The duration and discontinuation of cytotoxic therapy seems to be a particularly difficult matter. Hospice admission often signalled the end of this treatment. In a third of the patients, no decision was taken to stop chemotherapy despite the last dose being an average of just 1 week before death. The value of chemotherapy for patients who are too ill to return home is questioned. Seven patients were diagnosed as suffering from chemotherapy-induced sepsis and neutropenia either by hospice inpatient or home care teams, and were admitted to their acute centres accordingly. Most patients who died during the study period received terminal care in the hospice. Suggestions are made on improving professional education and communication, including the use of a 'chemotherapy card'.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashby M., Stoffell B. Therapeutic ratio and defined phases: proposal of ethical framework for palliative care. BMJ. 1991 Jun 1;302(6788):1322–1324. doi: 10.1136/bmj.302.6788.1322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Byrne M. Cancer chemotherapy and quality of life. BMJ. 1992 Jun 13;304(6841):1523–1524. doi: 10.1136/bmj.304.6841.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hillier R. Palliative medicine. BMJ. 1988 Oct 8;297(6653):874–875. doi: 10.1136/bmj.297.6653.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kearsley J. H. Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited? Br Med J (Clin Res Ed) 1986 Oct 4;293(6551):871–876. doi: 10.1136/bmj.293.6551.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lloyd B. W., Barnett P. Use of problem lists in letters between hospital doctors and general practitioners. BMJ. 1993 Jan 23;306(6872):247–247. doi: 10.1136/bmj.306.6872.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newton J., Eccles M., Hutchinson A. Communication between general practitioners and consultants: what should their letters contain? BMJ. 1992 Mar 28;304(6830):821–824. doi: 10.1136/bmj.304.6830.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubens R. D., Towlson K. E., Ramirez A. J., Coltart S., Slevin M. L., Terrell C., Timothy A. R. Appropriate chemotherapy for palliating advanced cancer. BMJ. 1992 Jan 4;304(6818):35–40. doi: 10.1136/bmj.304.6818.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sensky T., Catalan J. Asking patients about their treatment. BMJ. 1992 Nov 7;305(6862):1109–1110. doi: 10.1136/bmj.305.6862.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]